Lombard Odier Asset Management (Europe)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,000
Closed -$211K 261
2023
Q1
$211K Buy
+9,000
New +$257K 0.01% 270
2022
Q4
Sell
-6,500
Closed -$350K 291
2022
Q3
$350K Hold
6,500
0.02% 252
2022
Q2
$262K Buy
+6,500
New +$322K 0.01% 251

Other funds holding GH

Lombard Odier Asset Management (Europe)'s GH Position: Q2 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Guardant Health (GH) in Q2 2023, closing a stake of 9,000 shares — an estimated $211K sold.

Lombard Odier Asset Management (Europe) first reported a position in GH in Q2 2022 and held it in 3 quarters. The position peaked at $350K in Q3 2022. 301 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 9,000 Guardant Health shares in Q2 2023, an estimated $211K.
  • Lombard Odier Asset Management (Europe) first reported a position in Guardant Health in Q2 2022 and held it in 3 quarters.
  • Lombard Odier Asset Management (Europe)'s Guardant Health position peaked at $350K in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2023, filed 14 Aug 2023.